How do you manage severe lenalidomide-associated drug rash in a transplant-eligible patient with multiple myeloma?

A rash with lenalidomide occurs in up to a third of patients exposed, and it's likely that dose corresponds directly with rash severity. While excellent desensitization protocols appear effective (PMID 31400463), most of us want to be able to deal with this with a phone call or text message that inc...